| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/30/2013 | CN102327204B Oral care preparation and production method thereof |
| 01/30/2013 | CN102319390B Medicament for treating chronic cholecystitis |
| 01/30/2013 | CN102247550B Trollflower compound preparation and preparation method thereof |
| 01/30/2013 | CN102228676B Heparolysate injection pharmaceutical composition |
| 01/30/2013 | CN102228661B Chinese medicinal cholecystitis treatment mixture for treating chronic cholecystitis |
| 01/30/2013 | CN102228479B Medicine for treating oral diseases and preparation method thereof |
| 01/30/2013 | CN102210685B Application of ectoine and derivatives thereof in preparing medicament for preventing and treating digestive tract diseases caused by chemotherapy medicaments |
| 01/30/2013 | CN102210681B Application of ectoine and derivatives thereof in preparing medicament for treating digestive tract diseases |
| 01/30/2013 | CN102204975B Medicinal composition for treating acute and chronic enteritis |
| 01/30/2013 | CN102204950B Method for extracting flavonoid from liquorice waste residue |
| 01/30/2013 | CN102090559B Synergism of GOS and polyfructose |
| 01/30/2013 | CN101942013B HLA-DR9 restrictive regulatory T cell epitope of Hepatitis B virus core antigen and e antigen and application thereof |
| 01/30/2013 | CN101914160B Composite of hepatitis B virus core antigen and heat shock protein and preparation method and application thereof |
| 01/30/2013 | CN101912447B Rhizoma corydalis total alkaloids self-emulsifying drug delivery system and preparation method and application thereof |
| 01/30/2013 | CN101781300B Entecavir salt compound, preparation method and medicine application thereof |
| 01/30/2013 | CN101415433B Plant-based formulations for improving liver health |
| 01/30/2013 | CN101336978B Extraction method of total flavone of Hovenia dulcisThunb |
| 01/30/2013 | CN101108204B Application of flax root total flavone in preparing medicament for preventing and/or treating hepatitis |
| 01/29/2013 | US8362247 Prokineticin 1 receptor antagonists |
| 01/29/2013 | US8362042 Stable R(+)-lansoprazole amine salt and a process for preparing the same |
| 01/29/2013 | US8361968 Metastin derivatives and use thereof |
| 01/29/2013 | US8361485 Conditioned cell culture medium compositions and methods of use |
| 01/29/2013 | CA2668245C Improved laxative composition and method |
| 01/29/2013 | CA2631401C Methods for altering stool quality and/or stool frequency |
| 01/24/2013 | WO2013012954A2 Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides |
| 01/24/2013 | WO2013012662A2 Pharmaceutical compositions for rectal administration |
| 01/24/2013 | WO2013011996A1 Polyphosphoric acid composition containing polyphosphoric acid extracted from yeast cell, salt of polyphosphoric acid or solvate of polyphosphoric acid, and method for producing same |
| 01/24/2013 | WO2013010383A1 Intestine-hydrating and laxative drink and preparation method therefor |
| 01/24/2013 | WO2013010210A1 Oral compositions comprising an antacid, an anaesthetic and an inorganic matrix comprising silicon dioxide and titanium dioxide |
| 01/24/2013 | US20130024961 Methods of Modulating Thrombocytopenia and Modified Transgenic Pigs |
| 01/24/2013 | US20130023584 Theaflavin Compositions, Related Processes and Methods of Use |
| 01/24/2013 | US20130023583 Theaflavin Compositions, Related Processes and Methods of Use |
| 01/24/2013 | US20130023576 Pyrazole Compounds as CRTH2 Antagonists |
| 01/24/2013 | US20130023568 Benzimidazole Derivatives And Their Pharmaceutical Compositions And Uses |
| 01/24/2013 | US20130023562 Novel piperidine derivatives |
| 01/24/2013 | US20130023530 Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders |
| 01/24/2013 | US20130023526 Isoxazolines as Therapeutic Agents |
| 01/24/2013 | US20130023524 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it |
| 01/24/2013 | US20130023517 Therapeutic methods employing substituted piperidines which are CCR3 antagonists |
| 01/24/2013 | US20130023512 Compositions for Combating Beta-Lactamase-Medicated Antibiotic Resistance Using Beta-Lactamase Inhibitors Useful For Injection |
| 01/24/2013 | US20130023509 Hyaluronic acid based copolymers |
| 01/24/2013 | US20130023508 Hyaluronic acid based copolymers |
| 01/24/2013 | US20130023507 Hyaluronic acid based copolymers |
| 01/24/2013 | US20130023504 Modulation of Prostaglandin/Cyclooxygenase Metabolic Pathways |
| 01/24/2013 | US20130023503 Nk1 antagonists |
| 01/24/2013 | US20130023502 Substituted pyridinyl-pyrimidines and their use as medicaments |
| 01/24/2013 | US20130023495 Uses of dgat1 inhibitors |
| 01/24/2013 | US20130023493 Andrographis paniculata extract |
| 01/24/2013 | US20130023489 Compositions and methods for preventing and treating diseases and environmentally induced health disorders |
| 01/24/2013 | US20130023483 Template-fixed peptidomimetics with cxcr7 modulating activity |
| 01/24/2013 | US20130023469 Leptin for use in increasing liver regeneration |
| 01/24/2013 | US20130022695 Bacterial extract for digestive or urinary tract disorders and process for its preparation |
| 01/24/2013 | US20130022694 Method for treating or relieving inflammatory bowel disease |
| 01/24/2013 | US20130022689 Use of Amisulpride as an Anti-Emetic |
| 01/24/2013 | US20130022688 Use of Amisulpride as an Anti-Emetic |
| 01/24/2013 | US20130022681 Granules for pharmaceutical preparations, methods and apparatus for their production |
| 01/24/2013 | US20130022679 Controlled Release and Taste Masking Oral Pharmaceutical Composition |
| 01/24/2013 | US20130022675 Drug delivery system |
| 01/24/2013 | US20130022620 Assays and methods pertaining to pre-amyloid intermediates |
| 01/24/2013 | US20130022607 Mucosal vascular addressins and uses thereof |
| 01/24/2013 | US20130022605 Antagonists against tnfr1 and methods of use therefor |
| 01/24/2013 | US20130022587 Cycloalkyl-Substituted Imidazole Derivative |
| 01/24/2013 | US20130022586 Production and use of bacterial histamine |
| 01/24/2013 | US20130022580 Preparation and use of meristematic cells belonging to the dendrobium phalaenopsis, anisellia, polyrrhiza, vanilla, cattleya and vanda genera with high content of phenylpropanoids, hydrosoluble polysaccharides and extensins |
| 01/24/2013 | US20130022576 Compositions and methods for reducing the incidence of equine digestive disorders |
| 01/24/2013 | US20130022575 Systems and methods of replacing intestinal flora |
| 01/24/2013 | CA2841367A1 Oral compositions comprising an antacid, an anaesthetic and an inorganic matrix comprising silicon dioxide and titanium dioxide |
| 01/24/2013 | CA2841358A1 Pharmaceutical compositions for rectal administration |
| 01/24/2013 | CA2838793A1 Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides |
| 01/23/2013 | EP2548890A1 Anti MIF antibodies |
| 01/23/2013 | EP2548888A1 Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same |
| 01/23/2013 | EP2548576A1 Diagnosis of cancer using anti-desmoglein-3 antibodies |
| 01/23/2013 | EP2548559A1 Methods and compositions for treating gastrointestinal disorders |
| 01/23/2013 | EP2547765A1 Beta-propiolactone for inactivation of viruses in pharmaceutical pancreatic enzyme preparations |
| 01/23/2013 | EP2547348A1 Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions |
| 01/23/2013 | EP2547338A2 Imidazopyridine compounds, compositions and methods of use |
| 01/23/2013 | EP2547331A1 Gastro-resistant enzyme pharmaceutical compositions |
| 01/23/2013 | CN1919339B Cucurbitacin nano preparation comprising protein, preparation method and use thereof |
| 01/23/2013 | CN1606545B Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/23/2013 | CN102892760A Prophylactic and/or therapeutic agent for non-alcoholic steatohepatitis |
| 01/23/2013 | CN102892759A Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity |
| 01/23/2013 | CN102892421A Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders |
| 01/23/2013 | CN102892407A The use of amisulpride as anti-emetic |
| 01/23/2013 | CN102892303A Feed supplement comprising oligosaccharides and medium chain fatty acids |
| 01/23/2013 | CN102888426A Minicircle gene vector and its preparation method and use |
| 01/23/2013 | CN102888279A Extracting method of corn stigma essential oil |
| 01/23/2013 | CN102887954A Human anti-il-23 antibodies, compositions, methods and uses |
| 01/23/2013 | CN102886042A Combination containing complex nucleoside, glutathione and yeast extract and application of combination in aspects of alleviating hangover and protecting liver |
| 01/23/2013 | CN102886039A Preparation process of stomach pill of stomach pill of aucklandia and amomum fruit |
| 01/23/2013 | CN102886035A Medicament for treating chronic gastroenteropathy |
| 01/23/2013 | CN102886016A Traditional Chinese medicine preparation for treating cholecystic polypus |
| 01/23/2013 | CN102886013A Shiniu antipyretic oral liquid |
| 01/23/2013 | CN102886012A Pseudo-ginseng Wei shu tablet |
| 01/23/2013 | CN102886011A Traditional Chinese medicine for treating dyspepsia |
| 01/23/2013 | CN102886000A Preparation method of digestant pills |
| 01/23/2013 | CN102885999A Traditional Chinese medicine composition with indigestion effect and preparation method thereof |
| 01/23/2013 | CN102885996A Medicine for treating constipated acne |
| 01/23/2013 | CN102885990A Medicine for degrading transaminase and liver viruses and preparation method thereof |
| 01/23/2013 | CN102885989A Medicinal and edible health care product for protecting against chemical liver injury and preparation method for health care product |
| 01/23/2013 | CN102885978A Medicine for treating gastroesophageal reflux and preparation method thereof |